80 results
Page 4 of 4
6-K
EX-99.1
o0uopt3vpbgu dr
12 Nov 20
Third Quarter Interim Statement
11:30am
6-K
EX-99.1
irnjtm26u 721u
30 Sep 20
Current report (foreign)
11:00am
6-K
EX-99.1
6pji0y
18 Sep 20
MorphoSys and Incyte to Host Investor Event to Discuss the Unmet
8:12am
6-K
EX-99.1
v5k l05sth
25 Aug 20
Current report (foreign)
8:11am
6-K
EX-99.1
4o88v2yzru
7 Aug 20
MorphoSys Reports Second Quarter and First Half
12:37pm
6-K
EX-99.1
naslzm8
5 Aug 20
Half-Year Report January – June 2020
4:18pm
6-K
EX-99.2
82h3y
3 Aug 20
Current report (foreign)
1:10pm
6-K
EX-99.1
bezxjg4wheut7zzk4n
8 May 20
MorphoSys Reports First Quarter 2020 Results
6:25am
6-K
EX-99.1
foui cpysdmgmc3t
6 May 20
First Quarter Interim Statement
4:19pm
6-K
EX-99.1
3f1fmiepkqh1
24 Apr 20
MorphoSys Appoints Roland Wandeler, Ph.D., as Chief Commercial Officer
11:02am
6-K
EX-99.1
te3 h7bg76z
27 Mar 20
Current report (foreign)
3:29pm
6-K
EX-99.1
byq61trj5vlo1inuyv
20 Mar 20
Current report (foreign)
2:15pm
6-K
EX-99.1
pv0y7cl
5 Feb 20
Current report (foreign)
8:37am
6-K
EX-99.1
n5mdw8
12 Apr 19
Current report (foreign)
6:09am
6-K
EX-99.1
jmf0lirx977hc 48
21 Mar 19
Current report (foreign)
6:14am
6-K
EX-99.1
qjohf
15 Mar 19
2018 annual report Morphosys Engineering the Medicines of Tomorrow
6:27am
20-F
cwnbw cp4k
13 Mar 19
Annual report (foreign)
5:13pm
6-K
EX-99.1
2vvn2bwvvj2rf
17 May 18
Annual General Meeting of MorphoSys AG Elects New Supervisory
4:07pm